Flagler Health — $50M Series B for AI-Native Musculoskeletal Care Platform
ENTITYCompany Overview Flagler Health is developing what it describes as an "AI operating system" for musculoskeletal (MSK) care. The company has raised $50 million in a Series B funding round to build out this platform, targeting the high-volume, high-cost MSK care segment that includes back pain, joint replacements, and sports medicine. Platform Vision The AI operating system framing positions Flagler's platform as foundational infrastructure for MSK care delivery rather than a point solution. This approach aims to coordinate care workflows, clinical decision support, and patient engagement across the MSK care continuum — from initial symptom presentation through post-surgical rehabilitation. Market Context MSK conditions represent one of the largest cost drivers in US healthcare. AI-native approaches that can optimize care pathways, reduce unnecessary imaging or surgery, and improve rehabilitation adherence represent a significant commercial opportunity. The $50M Series B signals strong investor confidence in the MSK AI vertical as a distinct and fundable category within digital health. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.